- Angiotensin II inhibits Na+/K+ATPase activity in pulmonary artery smooth muscle cells via glutathionylation and with the involvement of a 15.6 kDa inhibitor protein.
Angiotensin II inhibits Na+/K+ATPase activity in pulmonary artery smooth muscle cells via glutathionylation and with the involvement of a 15.6 kDa inhibitor protein.
Indian journal of biochemistry & biophysics (2015-06-30)
Sayed Modinur Rahaman, Kuntal Dey, Tapati Chakraborti, Sajal Chakraborti
PMID26118122
ZUSAMMENFASSUNG
The role of angiotensin II in regulating Na+/K(+)-ATPase activity has been investigated in bovine pulmonary artery smooth muscle cells (BPASMCs). Our study reveals that angiotensin II inhibits the Na+/K+ATPase activity via glutathionylation of the pump with the involvement of an increase in NADPH oxidase-derived O2*-. Additionally, angiotensin II treatment to the cells increases the inhibitory potency of the 15.6 kDa inhibitor towards the Na+/K+ATPase activity.
MATERIALIEN
Produktnummer
Marke
Produktbeschreibung
Sigma-Aldrich
Hydroxylapatit, puriss., meets analytical specification of Ph. Eur., BP, FCC, E341, ≥90% (calculated on glowed substance)
Sigma-Aldrich
Hydroxylapatit, nanoparticles, dispersion, 10 wt. % in H2O, <200 nm particle size (BET)
Sigma-Aldrich
Hydroxylapatit, nanopowder, <200 nm particle size (BET), contains 5 wt. % silica as dopant, synthetic